Biotechnology Stocks II Performance Guide: Viridian Therapeutics, Inc. (VRDN)
VRDN has no dividends.
Table and Chart of VRDN Performance
See what a $1,000 investment in VRDN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VRDN Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $1,332.00 |
| End Date | Jul-26-2024 |
| End Price | $16.66 |
| # Prices | 121 |
| Min Date | Mar-31-2020 |
| Min Price | $6.69 |
| Max Date | Jul-31-2014 |
| Max Price | $1,332.00 |
| Total Return | -98.75% |
| Annualized Return | -35.24% |
| Current Value of $1,000 Purchase | $13 |
| Number Returns | 7,260 |
| Average Return | -46.82% |
| Number Profitable Returns | 1,352 |
| Percent Profitable Returns | 18.62% |
| Number Unprofitable Returns | 5,908 |
| Percent Unprofitable Returns | 81.38% |
| Profitable to Unprofitable Returns Ratio | 0.23 |
| VRDN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,042,860,000 |
| Beta | 1.150 | Price to Sales | 3,459.27 |
| Earnings per Share | $-4.4900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.602 |
| PRICE DATA | |
| 52 Week High | $24.18 |
| 52 Week Low | $10.93 |
| Analyst Target Price | $35.19 |
| 50-Day Moving Average | $13.15 |
| 200-Day Moving Average | $16.14 |
| FINANCIAL DATA | |
| Revenue per Share | $0.006 |
| Revenue | $288,000 |
| Profit Margin | 0% |
| Return on Equity | -46.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VRDN Compare Returns with S&P 500
VRDN Trendline Chart
VRDN Moving Average Chart
VRDN Stock Return Map - See Patterns of Gains and Losses
VRDN Stock Returns/Purchase Dates